tranSMART also was honored as two projects won awards during the Conference. The U-BIOPRED Project “The tranSMART-based U-BIOPRED Study and Knowledge Management Platforms”, funded by IMI, was awarded a Best Practice Award in Research and Drug Discovery. In addition, work by a team from Boehringer Ingelheim and ThomsonReuters was a CHI Poster Competition Winner for their poster on “A work-flow based tranSMART system enabling scientists for fast and reliable genomic analysis”.
Best Practice Award – Research and Discovery
One of the initial IMI projects, U-BIOPRED, was awarded a Best practice award in research and drug discovery for its knowledge management platform actively in use in the project that effectively combines data integration with a collaborative analysis effort.
U-BIOPRED is a large scale collaboration, 43 partners, but what is more remarkable is that the platform was built and expand in collaboration with another IMI project eTRIKS and the tranSMART Foundation.
Ioannis Pandis, postdoctoral fellow at Imperial College is one of the key drivers in making the platform happen said: “The effort to establish the U-BIOPRED tranSMART platform required some dynamic thinking and collaboration on multiple levels. This is clearly the best way to share and analyze complex translational research datasets.”
Complex translational research datasets are becoming the norm and it is efforts like these that will harness the power of the ongoing data explosion.
CHI Poster Competition Winner
A work-flow based tranSMART system enabling scientists for fast and reliable genomic analysis
Yirong Wang (Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, CT USA), Eugene Myshkin (Thomson Reuters, USA), Eugene Rakhmatulin (Thomson Reuters, USA), Sirimon O’Charoen (Thomson Reuters, USA), William Loging (Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, CT USA)